Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial  |
Reference |
Staphylococcus aureus (ATCC 29213) |
- |
- |
3000 - ? |
Naringin  |
1247 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
5000 - ? |
Reserpine  |
1033 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
5600 - ? |
Rosmarinus officinalis (Essential oil)  |
1352 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
5600 - ? |
Salvia officinalis (Essential oil)  |
1352 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
6250 - ? |
Eucalyptus globulus (Crude extract)  |
544 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
22400 - ? |
Triacetin  |
1352 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
? - 0.2 |
Gentamicin (Gentamycin, Garamycin)  |
68 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
? - 0.8 |
Tetracycline (Sumycin, Achromycin V, Steclin)  |
68 |
Staphylococcus aureus (ATCC 29213) |
- |
- |
? - 62.5 |
Cefoperazone/Sulbactam  |
411 |
Staphylococcus aureus (ATCC 2943) |
- |
- |
50 - ? |
Ampicillin (Omnipen)  |
137 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant + ESBL) |
- |
- |
>32 - ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin)  |
1055 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant + ESBL) |
- |
- |
>256 - ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin)  |
1055 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
≤0.016 - ? |
Triclosan  |
186 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
0.25 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)  |
1579 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
0.25 - ? |
Vancomycin (Vancocyn, Lyphocin)  |
186 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
1 - 2 |
A-80915A  |
1001 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
1 - ? |
Telavancin (TD-6424, Vibativ)  |
209 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
1 - ? |
Vancomycin (Vancocyn, Lyphocin)  |
1502 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
2 - ? |
A-80915B  |
1001 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox)  |
269 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
2 - ? |
Vancomycin (Vancocyn, Lyphocin)  |
269 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
8 - 16 |
Amikacin (Amikin)  |
1502 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
8 - ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin)  |
186 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
16 - 32 |
Pexiganan  |
14 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
64 - ? |
Nafcillin (Unipen, Nafcil)  |
269 |
Staphylococcus aureus (ATCC 33591 + methicillin-resistant) |
- |
- |
125 - ? |
Neomycin B  |
1502 |
Staphylococcus aureus (ATCC 33591 + methicillin-susceptible) |
- |
- |
<0.016 - ? |
NB2001  |
186 |
Staphylococcus aureus (ATCC 33591) |
- |
- |
0.25 - ? |
TR-700  |
615 |